Clinical trials: sponsored by Institut Paoli-Calmettes
Obstructive Jaundice, Biliary Stricture
Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis
The use of an endoprothesis in a pancreatic duct is a measure to minimize the incidence and severity of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis.
- Conditions
- Obstructive Jaundice, Biliary Stricture, Sphincter of Oddi Dysfunction
- Trial name
- ARCHIMEDE (NCT03977779)
- Testing
- Placement of ARCHIMEDES fast biodegradable stent during the Endoscopic Retrograde CholoangioPancreatography
- Where
- 2 sites in France
- Volunteers
- 46 people
- Sponsor
- Institut Paoli-Calmettes
Hematologic Neoplasms
Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients
Allogeneic (Allo) hematopoietic stem cell transplantation (HSCT) is a recognized curative procedure for hematological malignancies.
- Trial name
- HAPLOMUD (NCT02623309)
- Testing
- Allogeneic (Allo) hematopoietic stem cell transplantation
- Where
- 14 sites in France
- Volunteers
- 108 people
- Sponsor
- Institut Paoli-Calmettes
Bladder Cancer, Cystostomy; Complications
Evaluation of Naloxegol in the Prevention of POI After Cystectomy
Postoperative ileus (POI) is defined as a transient reduction of bowel motility that prevents effective transit of bowel content and tolerance of oral intake following surgical interventions, especially after radical cystectomy.
- Trial name
- ANTAGOCYST (NCT04219046)
- Testing
- Naloxégol oxalate
- Sponsor
- Institut Paoli-Calmettes
Kidney Cancer
Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic Therapy
In the current era of immune checkpoint inhibitors (ICI), the role and timing of nephrectomy remains unknown, particularly in cases of residual kidney disease after a major response at metastatic sites.
- Trial name
- NAMECAR (NCT06882486)
- Testing
- nephrectomy
- Where
- France
- Volunteers
- 60 people
- Sponsor
- Institut Paoli-Calmettes
Prostate Cancer
Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as Reference
To evaluate the negative predictive value of mpMRI in the detection of prostate cancer using cystoprostatectomy specimen as the reference
- Trial name
- NPV-MRI-02 (NCT03960112)
- Testing
- mpMRI
- Where
- 5 sites in France
- Volunteers
- 12 people
- Sponsor
- Institut Paoli-Calmettes
Acute Myeloid Leukemia, Myelodysplastic Syndromes
HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies
This study aims at evaluating the safety of an approach based on HLA-mismatched Microtransplantation without immunosuppressive treatment in patients With myeloid hemopathies who are ineligible to conventional allograft
- Trial name
- MICROSTEM (NCT03232268)
- Testing
- HLA-mismatched microtransplantation
- Where
- France
- Volunteers
- 25 people
- Sponsor
- Institut Paoli-Calmettes
Low Risk Prostate Cancer
Active Surveillance With or Without Apalutamide Treatment in Low Risk Prostate Cancer
Many prostate cancer are slow or non progressive forms that would never impair quality or quantity of like of life if undetected.
- Trial name
- PC-ARN (NCT03088124)
- Testing
- Apalutamide
- Where
- 13 sites in France
- Volunteers
- 93 people
- Sponsor
- Institut Paoli-Calmettes
Breast Cancers, Ovarian Cancers
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers
- Trial name
- GENEPSO (NCT03667417)
- Testing
- Questionnaires
- Where
- France
- Volunteers
- 5,000 people, healthy volunteers welcome
- Sponsor
- Institut Paoli-Calmettes
Kidney Cancer
Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents
Prospective research of Matrix Metalloproteinases (MMP) 2 and 9 as predictive biomarkers in metastatic kidney cancer patients treated with 2 anti angiogenic agents (Sunitinib or Pazopanib).
- Trial name
- MMP-REIN (NCT03185039)
- Testing
- Blood and tumor samples
- Where
- France
- Volunteers
- 50 people
- Sponsor
- Institut Paoli-Calmettes
Prostate Cancer
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
The primary objective of this study is to evaluate the performance of HR-TRUS in detection of prostate cancer lesions relative to whole mount section after radical prostatectomy as the reference.
- Trial name
- EXACTVU (NCT03679819)
- Testing
- HR-TRUS
- Where
- France
- Volunteers
- 32 people
- Sponsor
- Institut Paoli-Calmettes
Metastatic Prostate Cancer
Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to Castration
Prospective research of Natural Killer cells as predictive biomarkers to stratify patients likely to have longer response time to castration.
- Trial name
- NKPROSTATE (NCT02963155)
- Testing
- Blood samples
- Where
- France
- Volunteers
- 60 people
- Sponsor
- Institut Paoli-Calmettes
Caregivers
CONDOL01: Evaluation on the Experience of Bereavement, of a Medical Consultation, Proposed by a Letter of CONDOLence to the Patients' Relatives Versus Standard Practice After the Death of the Patient
The aim of this randomized multicenter study is to evaluate the impact in offering the condolence letter to the family caregivers (indicated as the reliable person by the patient himself at each hospitalization) and a bereavement…
- Trial name
- CONDOL01 (NCT02861625)
- Testing
- Letter of condolence and post-death medical consultation
- Where
- 2 sites in France
- Volunteers
- 432 people, healthy volunteers welcome
- Sponsor
- Institut Paoli-Calmettes
Solid and Hematologic Cancer
Feasibility Study of a Sports-Inspired Onco-Coaching Progranm for Young Adults i Cancer Remission
This is a single-center, non-randomized feasibility study. For this study, 19 young adults treated for cancer at the Paoli-Calmettes Institute will be included.This study includes interviews and questionnaires to assess the…
- Trial name
- rebond-jas (NCT07861971)
- Where
- France
- Volunteers
- 19 people
- Sponsor
- Institut Paoli-Calmettes
Early Triple-Negative Breast Cancer
Reduction of Neoadjuvant Treatment in Early Triple-Negative Breast Cancer
This multicenter phase II study evaluates a de-escalation strategy of neoadjuvant chemo-immunotherapy in patients with stage II early triple-negative breast cancer and tumor-infiltrating lymphocytes (TILs) ≥ 30%.
- Trial name
- DECREASE (NCT07857486)
- Testing
- Pembrolizumab
- Volunteers
- 84 people
- Sponsor
- Institut Paoli-Calmettes
Malignant Hemopathy
Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation
Description of the evolution of the biological characteristics of immune blood populations and biomarkers of interest in patients who have received allogeneic hematopoietic stem cell transplantation.
- Trial name
- SIA-CSH (NCT03965429)
- Testing
- Blood samples (additional tubes from care) longitudinal, Blood samples (additional tubes from care) at inclusion
- Where
- France
- Volunteers
- 1,020 people
- Sponsor
- Institut Paoli-Calmettes
Acute Myeloid Leukemia
Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE
The goal of this clinical trial is to learn about the efficacy of DASATINIB monotherapy in acute myeloid leukemia patients refractory to VENETOCLAX-AZACITIDINE.
- Trial name
- VEN-R DASA (NCT06055621)
- Testing
- Dasatinib
- Where
- France
- Volunteers
- 35 people
- Sponsor
- Institut Paoli-Calmettes
Pancreas Cancer
Evolution of Body Connection After Surgery
Evaluation of psychological impact of patients after pancreatectomy because of cancer diagnosis. Patients will be evaluated with questionnaires after and before intervention.
- Trial name
- COSI (NCT04422730)
- Testing
- Psychological evaluation
- Where
- France
- Volunteers
- 129 people
- Sponsor
- Institut Paoli-Calmettes
Colonic Cancer
Butyrophilins Role in Colon Cancer
quantification of BTNL molecules in colon cancer in order to determinate if their could be used as a prognostic marquer
- Trial name
- IMMUNOCOL (NCT04185272)
- Testing
- analysis of BTN and BTNL status
- Where
- France
- Volunteers
- 200 people
- Sponsor
- Institut Paoli-Calmettes
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Evaluation of 3 Different Doses of IV Busulfan
Albeit the safety of the stem cell transplantation procedure has been greatly improved, further refining the intensity of the conditioning is an important issue to explore, especially in patients with poor prognosis, the goal…
- Trial name
- AAA (NCT01985061)
- Testing
- BX2, BX3, BX4-Suspended
- Where
- France
- Volunteers
- 177 people
- Sponsor
- Institut Paoli-Calmettes
Acute Leukemia, Non Hodgkin Lymphoma
Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen
This study is an extension to younger patients of the currently ongoing national, multicenter, open-label, randomized phase III HAPLOMUDELDERLY which evaluates elderly patients with hematological malignancies, justifying an…
- Conditions
- Acute Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma
- Trial name
- HaploMUD-RIC (NCT03595800)
- Testing
- Hematopoietic stem cells transplantation
- Where
- France
- Volunteers
- 9 people
- Sponsor
- Institut Paoli-Calmettes